• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,649.84 382.50
( 0.52%)
Global Indices
Nasdaq
51,095.09 41.63
(0.08%)
Dow Jones
7,620.62 19.56
(0.26%)
Hang Seng
66,649.95 -284.38
(-0.42%)
Nikkei 225
10,313.41 -95.87
(-0.92%)
Forex
USD-INR
94.75 -1.18
(-1.23%)
EUR-INR
110.47 -1.07
(-0.96%)
GBP-INR
127.45 -1.26
(-0.98%)
JPY-INR
0.59 -0.01
(-1.17%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
375.7898972
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
33.42
107608.15
EPS(TTM)
Face Value()
Div & Yield %
38.58
1
0.62
 

Dr Reddy's Laboratories consolidated net profit declines 86.14% in the March 2026 quarter
May 12,2026
Net profit of Dr Reddy's Laboratories declined 86.14% to Rs 220.90 crore in the quarter ended March 2026 as against Rs 1593.30 crore during the previous quarter ended March 2025. Sales declined 11.64% to Rs 7516.20 crore in the quarter ended March 2026 as against Rs 8506.00 crore during the previous quarter ended March 2025.

For the full year,net profit declined 25.80% to Rs 4196.00 crore in the year ended March 2026 as against Rs 5655.10 crore during the previous year ended March 2025. Sales rose 3.19% to Rs 33593.30 crore in the year ended March 2026 as against Rs 32553.50 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales7516.208506.00 -12 33593.3032553.50 3
OPM %5.0923.49 -19.2126.26 -
PBDT756.802459.90 -69 7451.509383.20 -21
PBT199.702005.20 -90 5392.707679.50 -30
NP220.901593.30 -86 4196.005655.10 -26